Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
47,000
Frequently Asked Questions
What is Market Cap of Lilly(Eli) & Co?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Lilly(Eli) & Co market cap is $781.25B.
What is the 52-week high for Lilly(Eli) & Co?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Lilly(Eli) & Co 52 week high is $935.63 as of October 25, 2025.
What is the 52-week low for Lilly(Eli) & Co?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Lilly(Eli) & Co 52 week low is $623.78 as of October 25, 2025.
What is the PE ratio of Lilly(Eli) & Co?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Lilly(Eli) & Co’s P/E ratio is 54.74.
What is the Price-to-Book ratio of Lilly(Eli) & Co?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Lilly(Eli) & Co P/B ratio is 42.7717.
What is the 50-day moving average of Lilly(Eli) & Co?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Lilly(Eli) & Co 50-day moving average is $767.50.
